2020-news

Nemera News

  • Seen in the press: Nemera’s article featured in September ‘Drug Development & Delivery’

    September 10, 2020

    “Smart, interactive and automated devices ergo ‘electronic’ are the future of drug delivery devices” Drug Development Delivery’s latest issue features Nemera’s article titled: magazine includes an article from Nemera: ‘Mapping the regulatory strategy to better navigate electronic drug delivery device development for patient safety & security’ Smart, interactive and automated devices ergo ‘electronic’ are the future of drug delivery devices. And

    Read more
  • 1 year anniversary Nemera - Insight

    Nemera’s Insight Innovation Center celebrates a year of successful integration of expanded services!

    July 28, 2020

    Nemera’s Insight Innovation Center celebrates a year of successful integration of expanded services! In August 2019, global drug delivery leader Nemera acquired top innovation services firm Insight Product Development. Today, Nemera’s Insight Innovation Center offers end-to-end development services from early to late-stage with design research, user experience design, engineering, and human factors. We are the ultimate partner for combination product

    Read more
  • bioscience-today-dermal-post

    Seen in the press: Nemera’s article featured in June ‘Bioscience Today’

    June 29, 2020

    Nemera’s takes dermal treatments to millions of patients Bioscience Today’s latest issue features Nemera’s article on how we strike the perfect balance of ensuring safety of our dermal drug delivery devices whilst fulfilling regulatory requirements and patient needs. Read more from our Category Managers Audrey Chandra and Raphaele Audibert. Nemera has been working in the dermal field for the past

    Read more
  • Page-article

    Seen in the press: Nemera’s CEO interview in ‘The Pharma Post’ special COVID-19 edition

    May 5, 2020

    “This is a significant learning opportunity for us as a global community.” Marc Hämel, our CEO shares his thoughts on leading Nemera during the coronavirus pandemic in Pharma Post’s Special issue ‘Pharma Post Covid-19’. “When the COVID-19 outbreak began in China, we were all hearing about it but the scale of the spread of the virus was still unknown. We had created and activated a business

    Read more
  • Image-post-réseaux-sociaux

    Seen in the press: Nemera’s article featured in April ‘Pulmonary & Nasal Drug delivery’

    April 17, 2020

    Nemera’s “RetroNose” concept makes it to On Drug Delivery! The recently published “Pulmonary & Nasal Drug delivery” magazine features Nemera’s article:  “RETRONOSE: IMPROVING NASAL DELIVERY THROUGH NEW AND IMPROVED DEVICE”. In this article, Laurent Vecellio, PhD, Research Engineer, CEPR, INSERM U1100, University of Tours, and Scientific Director, Nemera; Déborah Le Pennec, Research Technician, CEPR, INSERM U1100, University of Tours; Guillaume

    Read more
  • Nemera-Safe'n'Sound-2,25 ml

    Introducing our innovative Safe’n’Sound® in 2.25 mL size

    March 2, 2020

    “Introducing our innovative Safe’n’Sound® in 2.25 mL size”: premium add-on and highly customizable passive safety devices adapted to your complex injectable formulations. The platform is suitable for low fill volumes and high viscosity formulations. It is robust against shocks and vibrations, and can run with manual and fully automated assembly lines.” The growing prevalence of chronic diseases, along with the

    Read more
  • gender equality

    Nemera is committed to Gender Equality

    February 26, 2020

    Nemera is committed to Gender Equality The Gender Equality Index at Nemera Declared the “most important cause of the next five years” by the President of the French Republic, Gender Equality is at the heart of government priorities. Within this context, new measures were put in place by Decree No. 2019-15 of January 8, 2019, according to which all French

    Read more
  • Flonase-image-

    Flonase approved by U.S.FDA

    February 20, 2020

    Nemera metering dose pump and actuator for Flonase Allergy Relief has been approved by the U.S. FDA Nemera, one of the world leaders in the design, development and manufacturing of drug delivery solutions, is happy to announce that its SP270+ metering dose pump and actuator were recently approved by the U.S. Food and Drug Administration (FDA) for Flonase Allergy Relief.

    Read more
  • 2020-02-11 image-combinées-1

    Seen in the press: Nemera’s article featured in the last ‘European Pharmaceutical Manufacturer’ magazine

    February 13, 2020

    “European Pharmaceutical Manufacturer” magazine features Nemera’s article about innovation which is bringing new advantages for pharma customers. The recently published “European Pharmaceutical Manufacturer” magazine includes an article from Nemera: “How innovation is bringing new advantages for pharma customers”. In this article, Craig Scherer, Marketing Director for the Insight Innovation Center of Nemera, discusses how the company’s extended capabilities in front-end innovation bring new

    Read more
  • ODD-Feb2020 ODD-Feb2020 LEVERAGING THE PATIENT JOURNEY TO OPTIMISE DEVICE USE AT HOME

    Seen in the press: Nemera’s article featured in February ‘Prefilled syringes & Injection Drug delivery’

    February 10, 2020

    “Prefilled Syringes & Injection Drug delivery” magazine features Nemera’s article about the importance of device optimization to increase patient safety during self-administration of medication. The recently published “Prefilled syringes & Injection Drug delivery” magazine includes an article from Nemera:  “LEVERAGING THE PATIENT JOURNEY TO OPTIMISE DEVICE USE AT HOME”. In this article, Séverine Duband, Global Category Manager, and Mark Tunkel, Director

    Read more